Status:
UNKNOWN
COVID-19 Induced Telogen Effluvium
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Covid19
Telogen Effluvium
Eligibility:
All Genders
18+ years
Brief Summary
This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection
Detailed Description
Telogen effluvium (TE) is one of the most common causes of non-scarring alopecia. During the COVİD-19 pandemic, there is an increased number of Telogen effluvium patients.This study inquires about the...
Eligibility Criteria
Inclusion
- Sars-CoV-2 infection in the past year
Exclusion
- Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 27 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04834102
Start Date
January 27 2021
End Date
April 27 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medeniyet University
Istanbul, Kadıköy, Turkey (Türkiye), 34720